<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="022901-2018"
            EDITION="2018012">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-023431-001</RECEPTION_ID>
      <DELETION_DATE>20180426</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>12</NO_OJ>
         <DATE_PUB>20180118</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 012-022901</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:022901-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>http://chr-orleans.fr</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33694000">Diagnostic agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRK21">Ain</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRB06">Loiret</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="FRK21">Ain</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR104">Essonne</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR101">Paris</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRK14">Puy-de-Dôme</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR103">Yvelines</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">4860058</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 112-225058</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180116</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Орлеан</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Ορλεάνη</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Orleans</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Orleans</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Orleanas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Orleāna</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Orleans</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Orlean</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Orleães</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Orleans</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Orléans</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">Centre hospitalier régional d'Orléans</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Centre hospitalier régional d'Orléans</OFFICIALNAME>
               <ADDRESS>14 avenue de l'Hôpital, CS 86709</ADDRESS>
               <TOWN>Orléans Cedex 2</TOWN>
               <POSTAL_CODE>45067</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 238744040</PHONE>
               <E_MAIL>cellule.marches-dal@chr-orleans.fr</E_MAIL>
               <n2016:NUTS CODE="FRB06"/>
               <URL_GENERAL>http://chr-orleans.fr</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Établissement de santé</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fourniture de trousses, générateurs, précurseurs et médicaments radio pharmaceutiques pour le service de médecine nucléaire du centre hospitalier régional d'Orléans AO 2017-47</P>
            </TITLE>
            <REFERENCE_NUMBER>AO2017-47</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Marché à bons de commande conclu sans montant ni quantité. Le marché est conclu pour une durée de 1 an reconductible 3 fois. La durée totale du marché ne peut excéder 4 ans, jusqu'au 30.11.2021.</P>
               <P>Les prestations des lots 1 à 35 feront l'objet d'un accord-cadre à bons de commande conclu en mono titularisation.</P>
               <P>Les prestations des lots 36, 37, 38, et 39 feront l'objet d'un accord-cadre à bons de commande conclu en multi titularisation.</P>
               <P>Les pourcentages attribués sont détaillés comme suit:</P>
               <P>— lot 36 (18fdg):</P>
               <P>—— 80 % du lot au fournisseur classé nº 1,</P>
               <P>—— 15 % du lot au fournisseur classé nº 2,</P>
               <P>—— 5 % du lot au fournisseur classé nº 3.</P>
               <P>— lots 37 (18fcholine), 38 (18fdopa), et 39 (18fna):</P>
               <P>—— 70 % du lot au fournisseur classé nº 1,</P>
               <P>—— 20 % du lot au fournisseur classé nº 2,</P>
               <P>—— 10 % du lot au fournisseur classé nº 3.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">4860058</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Lots de 1 à 39</P>
               </TITLE>
               <LOT_NO>39</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33694000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRK21"/>
               <SHORT_DESCR>
                  <P>— lot 1 acide dimercaptosuccinique pour marquage tc 99 m/,</P>
                  <P>— lot 2 ac antigranulocyte pour marquage au tc 99 m/,</P>
                  <P>— lot 3 albumine humaine pour marquage tc 99 m 1/,</P>
                  <P>— lot 4 DTPA pour marquage au tc 99 m/,</P>
                  <P>— lot 5 macroagregats d'albumine hum/,</P>
                  <P>— lot 6 nanocolloides pour lymphoscintigraphie/,</P>
                  <P>— lot 7 oxidronate pour marquage au tc 99 m/,</P>
                  <P>— lot 8 sestamibi pour marquage au tc 99 m/,</P>
                  <P>— lot 9 sulfure de rhénium colloidal technecie/,</P>
                  <P>— lot 10 tetrofosmin pour marquage au tc 99 m/,</P>
                  <P>— lot 11 traceur évaluation du débit plasmatique rénal/,</P>
                  <P>— lot 12 trousse pour marquage in vitro des leucocytes au tc 99 m/,</P>
                  <P>— lot 13 trousse pour marquage in vivo hématies tc 99 m/,</P>
                  <P>— lot 14 trousse a marquer au tc 99m pour exploration des récepteurs à la somatostatine/,</P>
                  <P>— lot 15 traceurs pour scintigraphie des voies biliaires/,</P>
                  <P>— lot 16 générateur de tc 99 m/,</P>
                  <P>— lot 17 traceur de ventilation pulmonaire/,</P>
                  <P>— lot 18 chromate 51 de sodium/,</P>
                  <P>— lot 19 oxinate d'indium 111/,</P>
                  <P>— lot 20 chlorure de strontium 89/,</P>
                  <P>— lot 21 chlorure de thallium 201/,</P>
                  <P>— lot 22 edetate de chrome 51/,</P>
                  <P>— lot 23 erbium 169 colloïde/,</P>
                  <P>— lot 24 iode 123 iodure de sodium/,</P>
                  <P>— lot 25 6 iodomethylnorcholesterol iode 131/,</P>
                  <P>— lot 26 iode 131 — solution d'iodure de sodium/,</P>
                  <P>— lot 27 iodure de sodium — iode 131 gelule/,</P>
                  <P>— lot 28 ioflupane marque à l'iode 123/,</P>
                  <P>— lot 29 lexidronam de samarium 153/,</P>
                  <P>— lot 30 MIBG marquée à l'iode 123/,</P>
                  <P>— lot 31 pentetate d'indium 111/,</P>
                  <P>— lot 32 pentetreotide chlorure d'indium 111/,</P>
                  <P>— lot 33 chlorure d'indium 111/,</P>
                  <P>— lot 34 rhénium 186 colloïde/,</P>
                  <P>— lot 35 yttrium 90 colloïde/,</P>
                  <P>— lot 36 solution injectable 18 FDG (fludésoxyglucose)/,</P>
                  <P>— lot 37 solution injectable de fluorocholine/,</P>
                  <P>— lot 38 solution injectable de fluorodopa/,</P>
                  <P>— lot 39 solution injectable de fluorure de sodium NaF.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Valeur technique — lots de 1 à 15 (mono-attribution)</AC_CRITERION>
                  <AC_WEIGHTING>75</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Valeur technique — lots de 16 à 17 (mono-attribution)</AC_CRITERION>
                  <AC_WEIGHTING>75</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Valeur technique — lots 18 à 35 (mono-attribution)</AC_CRITERION>
                  <AC_WEIGHTING>75</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Valeur technique — lots 36 et 39 (multi-attribution)</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Lots 1 à 15 (transport inclus)</AC_CRITERION>
                  <AC_WEIGHTING>25</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Lots 16 à 17 (transport inclus)</AC_CRITERION>
                  <AC_WEIGHTING>25</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Lots 18 à 35 prix unitaire et coût d'utilisation (transport inclus)</AC_CRITERION>
                  <AC_WEIGHTING>25</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Lots 36 à 39 par dose (transport inclus)</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 112-225058</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>172-573</CONTRACT_NO>
            <LOT_NO>36 37 38</LOT_NO>
            <TITLE>
               <P>36 (15 %) / 37 (70 %) / 38 (70 %)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Advanced Accelerator Application</OFFICIALNAME>
                     <ADDRESS>20 rue Diesel</ADDRESS>
                     <TOWN>01630-Saint-Genis-Pouilly</TOWN>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK21"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">859320</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">859320</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>172-574</CONTRACT_NO>
            <LOT_NO>3-4-6-7-8-9-11-13-16-21-23-25-34-35-37-38-39</LOT_NO>
            <TITLE>
               <P>37 (10 %) / 38 (30 %) / 39 (30 %)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Groupe Curium — CIS Bio International</OFFICIALNAME>
                     <ADDRESS>BP 32</ADDRESS>
                     <TOWN>Gif-sur-Yvette</TOWN>
                     <POSTAL_CODE>91192</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR104"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1004980</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1004980</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>172-574</CONTRACT_NO>
            <LOT_NO>1-5-24-27-30</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mallinckrodt</OFFICIALNAME>
                     <ADDRESS>2 bis rue Louis Armand</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75015</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR101"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">232702</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">232702</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>172-575</CONTRACT_NO>
            <LOT_NO>36</LOT_NO>
            <TITLE>
               <P>36 (5 %)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Laboratoire Cyclopharma</OFFICIALNAME>
                     <ADDRESS>3 rue Marie Curie, biopôle Clermont-Limagne</ADDRESS>
                     <TOWN>Saint-Beauzire</TOWN>
                     <POSTAL_CODE>63360</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK14"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">137900</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">137900</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>172-576</CONTRACT_NO>
            <LOT_NO>10-12-18-20-22-28</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare SA</OFFICIALNAME>
                     <ADDRESS>24 avenue de l'Europe — CS 20529</ADDRESS>
                     <TOWN>Velizy Cedex</TOWN>
                     <POSTAL_CODE>78457</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR103"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">660956</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">660956</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="6">
            <CONTRACT_NO>172-577</CONTRACT_NO>
            <LOT_NO>36-37-39</LOT_NO>
            <TITLE>
               <P>36 (80 %) / 37 (20 %) / 39 (70 %)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-23</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Petnet Solutions</OFFICIALNAME>
                     <ADDRESS>15 rue des Pyrénées — ZI du Bois Chaland — CE 5605 Lisses</ADDRESS>
                     <TOWN>Evry Cedex</TOWN>
                     <POSTAL_CODE>91056</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR104"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1964200</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1964200</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal administratif d'Orléans</OFFICIALNAME>
               <ADDRESS>28 rue de la Bretonnerie</ADDRESS>
               <TOWN>Orléans Cedex 1</TOWN>
               <POSTAL_CODE>45057</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 238775900</PHONE>
               <E_MAIL>greffe.ta-orleans@juradm.fr</E_MAIL>
               <FAX>+33 238538516</FAX>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Tribunal administratif d'Orléans</OFFICIALNAME>
               <ADDRESS>28 rue de la Bretonnerie</ADDRESS>
               <TOWN>Orléans Cedex 1</TOWN>
               <POSTAL_CODE>45057</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 238775900</PHONE>
               <E_MAIL>greffe.ta-orleans@juradm.fr</E_MAIL>
               <FAX>+33 238538516</FAX>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-01-16</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
